Higher positive expression of CD9 has served as a good prognostic marker in breast, lung, colon, and pancreatic carcinomas [55,63,64], as it is thought to have a metastatic suppressor role by inhibiting tumor cell motility, at least in vitro [65,66]. This evidence concerns the gene CD9 and neoplasm.